Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Ball who wrote ()	6/24/1996 9:20:00 PM
From: Jinping Shi	of 496

About the Waffle, the disproval for initial use resulted from lack of a strong trial. Their support trial contains only 30-40 observations. IMO, however, the strong use of this drug delivery tech should be on the initial surgery where more survival can be achieved. Generally, we do not expect the patients with recurrent tumor can live much longer. The problem is how to calculate the value of the stock. I'd like to know more on the technical part of the calculation. TIA, Jinping

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next